phosphoserine has been researched along with 2-tert-butylhydroquinone in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Jaiswal, AK; Niture, SK | 1 |
Bown, J; Deeni, YY; Kankia, IH; Khalil, HS; Langdon, SP | 1 |
2 other study(ies) available for phosphoserine and 2-tert-butylhydroquinone
Article | Year |
---|---|
INrf2 (Keap1) targets Bcl-2 degradation and controls cellular apoptosis.
Topics: Adaptor Proteins, Signal Transducing; Animals; Antioxidants; Apoptosis; bcl-2-Associated X Protein; Carrier Proteins; Cell Line, Tumor; Cell Survival; Cullin Proteins; Cytoskeletal Proteins; DNA Fragmentation; Etoposide; Gamma Rays; Humans; Hydroquinones; Intracellular Signaling Peptides and Proteins; Kelch-Like ECH-Associated Protein 1; Lung Neoplasms; Lysine; Mice; Phosphorylation; Phosphoserine; Protein Binding; Protein Processing, Post-Translational; Protein Stability; Protein Structure, Tertiary; Proto-Oncogene Proteins c-bcl-2; Ubiquitination; Ultraviolet Rays; Up-Regulation | 2011 |
NRF2 Regulates HER2 and HER3 Signaling Pathway to Modulate Sensitivity to Targeted Immunotherapies.
Topics: Antibodies, Monoclonal, Humanized; Antioxidant Response Elements; Base Sequence; Cell Line, Tumor; Cell Proliferation; Computer Simulation; Cytoprotection; Down-Regulation; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Heme Oxygenase-1; Humans; Hydroquinones; Immunotherapy; Molecular Sequence Data; Molecular Targeted Therapy; NF-E2-Related Factor 2; Phosphorylation; Phosphoserine; Proto-Oncogene Proteins c-akt; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, ErbB-3; RNA, Small Interfering; Signal Transduction; Trastuzumab | 2016 |